Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 220.30M | £ 248.10M | £ 166.00M | £ 184.50M | £ 143.20M |
Total Assets | £ 1.71B | £ 1.76B | £ 1.54B | £ 1.49B | £ 1.47B |
Total Debt | £ 23.40M | £ 22.10M | £ 0.00 | £ 26.70M | £ 0.00 |
Net Debt | £ -196.90M | £ -226.00M | £ -166.00M | £ -157.80M | £ -143.20M |
Total Liabilities | £ 661.90M | £ 713.30M | £ 613.40M | £ 596.90M | £ 544.70M |
Stockholders Equity | £ 1.04B | £ 1.04B | £ 926.80M | £ 889.40M | £ 922.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |